KLRK1 and cancer: Analogously, in cancer, NK cells mediate cytotoxicity against tumour cells through direct interactions based on the presence of NKG2D ligands (which are upregulated in sarcomas) or absence of MHC class I expression (such as in lymphomas) of NK cell receptor ligands on cancer cells (29–31).